-
C413899-5mgInformationCCT251545 CCT251545 is a potent, orally bioavailable inhibitor of WNT signaling with IC50 of 5 nM in 7dF3 cells. CCT251545 also act as a selective chemical probe for exploring the role of CDK8 and CDK19 in human disease.TargetsCDK8 :
-
-
-
C288360-100mgSelective RARβ agonist.
-
C288360-10mgSelective RARβ agonist.
-
C288360-1mgSelective RARβ agonist.
-
C288360-25mgSelective RARβ agonist.
-
C288360-50mgSelective RARβ agonist.
-
C288360-5mgSelective RARβ agonist.
-
C287183-100mgSelective RARβ/γ antagonist.
-
C287183-10mgSelective RARβ/γ antagonist.
-
C287183-1mgSelective RARβ/γ antagonist.